The Association of the British Pharmaceutical Industry

Medicines are transforming our lives like never before. We want the UK to be the best place in the world to research, develop and use the medicines of the future.

FIND OUT MORE
 

Facts and Figures

Members

Online members portal

My ABPI members can log in for bespoke content and services

MORE ABOUT ABPI MEMBERSHIP

News

01 July 2020

ABPI response to Government R&D Roadmap

The Government has published its R&D Roadmap with plans to cement the UK as the world’s leading research and science superpower.

30 June 2020

Pharmaceutical industry invests £381 million in UK R&D collaborations - 2019 data on Disclosure UK

The data published on Disclosure UK today shows that the industry invested £381.2 million on R&D activities in the UK during 2019, up from £377.3million in 2018.

19 June 2020

ABPI consults on new-look Code of Practice

The ABPI is launching a public consultation on the proposed 2021 ABPI Code of Practice for the pharmaceutical industry from today. The aim is to create a new look, more user-friendly ABPI Code of Practice. 

18 June 2020

ABPI response to antibiotic development scheme

The Department of Health has announced that a scheme to kickstart the development of new antibiotics by offering to pay pharmaceutical companies upfront for their work will start this week. 

Publications

Industry information

Life Sciences Recovery Roadmap


Blog

18 June 2020

Celebrating #WomenInStem for Womenspire

Before the coronavirus pandemic, this Thursday would have been the annual Chwarae Teg Womenspire Awards 2020 - celebrating the achievements of women from all backgrounds and stages in life or work across Wales. 

25 May 2020

Gavi: Partnering to protect future generations from infectious diseases

As Gavi marks its twentieth anniversary, a new report from the ABPI and IFPMA looks at the past successes of the Vaccines Alliance and what the future holds. Richard Torbett looks ahead to that commitment to protect future generations from infectious diseases.

Twitter